مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

2,242
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

1

Information Journal Paper

Title

IMPORTANCE OF EPIGENETIC CHANGES IN THE THYROID CANCER INCIDENCE AND THEIR THERAPEUTIC APPLICATIONS (REVIEW ARTICLE)

Pages

  1-24

Abstract

 Thyroid cancer, the most common endocrine malignancy worldwide, originates from follicular epithelial cells. It is classified as a well-differentiated THYROID CARCINOMA (WDTC) -follicular (FTC) and papillary types (PTC) -, poorly differentiated THYROID CARCINOMAs (PDTC), anaplastic THYROID CARCINOMA (ATC), and parafollicular calcitonin producing cells include medullary THYROID CARCINOMA (MTC). “Epigenetic” refers to the study of heritable changes in gene expression that occur without any alteration in the pattern of the primary DNA sequence. Growing evidence shows that EPIGENETIC changes play important roles in THYROID CARCINOMAs and, together with genetic changes, lead to tumorigenesis. EPIGENETIC silencing of various genes specific for thyroid differentiation have been detected in thyroid tumors. These changes in tumor-promoting and tumor suppressor genes also contribute to the dysregulation of thyrocyte growth and other aspects of tumorigenesis. However, at present, no promising treatment is available for advanced thyroid cancer, which is unresponsive to radioiodine. Biologically targeted therapies for advanced THYROID CARCINOMAs have been proposed based on the recognition of main oncogenic mutations. In this review we discuss the most frequent EPIGENETIC variations in different types of thyroid cancer, EPIGENETIC strategies for treating this carcinoma, and experimental data and clinical trials, particularly those that use deacetylase inhibitors and demethylating agents.

Cites

References

Cite

APA: Copy

ZARKESH, MARYAM, TAGHADDOSI, MAHDI, AZIZI, FEREIDOUN, ZADEH VAKILI, AZITA, & HEDAYATI, MAHDI. (2014). IMPORTANCE OF EPIGENETIC CHANGES IN THE THYROID CANCER INCIDENCE AND THEIR THERAPEUTIC APPLICATIONS (REVIEW ARTICLE). PATHOBIOLOGY RESEARCH (MODARES JOURNAL OF MEDICAL SCIENCES), 17(3), 1-24. SID. https://sid.ir/paper/80977/en

Vancouver: Copy

ZARKESH MARYAM, TAGHADDOSI MAHDI, AZIZI FEREIDOUN, ZADEH VAKILI AZITA, HEDAYATI MAHDI. IMPORTANCE OF EPIGENETIC CHANGES IN THE THYROID CANCER INCIDENCE AND THEIR THERAPEUTIC APPLICATIONS (REVIEW ARTICLE). PATHOBIOLOGY RESEARCH (MODARES JOURNAL OF MEDICAL SCIENCES)[Internet]. 2014;17(3):1-24. Available from: https://sid.ir/paper/80977/en

IEEE: Copy

MARYAM ZARKESH, MAHDI TAGHADDOSI, FEREIDOUN AZIZI, AZITA ZADEH VAKILI, and MAHDI HEDAYATI, “IMPORTANCE OF EPIGENETIC CHANGES IN THE THYROID CANCER INCIDENCE AND THEIR THERAPEUTIC APPLICATIONS (REVIEW ARTICLE),” PATHOBIOLOGY RESEARCH (MODARES JOURNAL OF MEDICAL SCIENCES), vol. 17, no. 3, pp. 1–24, 2014, [Online]. Available: https://sid.ir/paper/80977/en

Related Journal Papers

Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button